Sandbox Reserved 896: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Sandbox_reserved_Karen_Glass_2020}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | {{Sandbox_reserved_Karen_Glass_2020}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
== | ==Structural and Functional Overview of Human BRD2 BD1 Bromodomain== | ||
<StructureSection load='6ddi' size='340' side='right' caption='Human BRD2(BD1) in Complex with Tetrahydroquinolone Analog' scene=''> | <StructureSection load='6ddi' size='340' side='right' caption='Human BRD2(BD1) in Complex with Tetrahydroquinolone Analog' scene=''> | ||
This is a default text for your page ''''''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | This is a default text for your page ''''''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | ||
Revision as of 22:39, 3 March 2020
| This Sandbox is Reserved from Jan 13 through July 31, 2020 for use in the course Protein Structure in Drug Discovery taught by Karen C. Glass at the ACPHS, Colchester, United States. This reservation includes Sandbox Reserved 895 through Sandbox Reserved 901. |
To get started:
More help: Help:Editing |
Structural and Functional Overview of Human BRD2 BD1 Bromodomain
| ||||||||||||
References
|
